HomeCompareCYTHW vs PEP

CYTHW vs PEP: Dividend Comparison 2026

CYTHW yields 6250.00% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYTHW wins by $547038161900822.06M in total portfolio value
10 years
CYTHW
CYTHW
● Live price
6250.00%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$547038161900822.19M
Annual income
$530,345,833,482,145,900,000.00
Full CYTHW calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — CYTHW vs PEP

📍 CYTHW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYTHWPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYTHW + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CYTHW pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYTHW
Annual income on $10K today (after 15% tax)
$531,250.00/yr
After 10yr DRIP, annual income (after tax)
$450,793,958,459,824,000,000.00/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, CYTHW beats the other by $450,793,958,459,823,950,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYTHW + PEP for your $10,000?

CYTHW: 50%PEP: 50%
100% PEP50/50100% CYTHW
Portfolio after 10yr
$273519080950411.16M
Annual income
$265,172,916,741,072,980,000.00/yr
Blended yield
96.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

CYTHW
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-46.3
Piotroski
2/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYTHW buys
0
PEP buys
0
No recent congressional trades found for CYTHW or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYTHWPEP
Forward yield6250.00%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$547038161900822.19M$141.9K
Annual income after 10y$530,345,833,482,145,900,000.00$61,875.67
Total dividends collected$545916230838674.88M$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: CYTHW vs PEP ($10,000, DRIP)

YearCYTHW PortfolioCYTHW Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$635,700$625,000.00$10,849$509.42+$624.9KCYTHW
2$37,812,208$37,132,009.35$11,969$750.47+$37.80MCYTHW
3$2,104,624,511$2,064,165,448.17$13,500$1,124.14+$2104.61MCYTHW
4$109,626,980,731$107,375,032,504.06$15,680$1,721.66+$109626.97MCYTHW
5$5,344,419,538,811$5,227,118,669,428.94$18,929$2,715.34+$5344419.52MCYTHW
6$243,874,608,189,950$238,156,079,283,422.40$24,023$4,450.80+$243874608.17MCYTHW
7$10,417,442,627,867,752$10,156,496,797,104,504.00$32,510$7,669.92+$10417442627.84MCYTHW
8$416,612,895,336,954,560$405,466,231,725,136,060.00$47,709$14,093.60+$416612895336.91MCYTHW
9$15,600,306,933,342,350,000$15,154,531,135,331,807,000.00$77,415$28,083.48+$15600306933342.27MCYTHW
10$547,038,161,900,822,200,000$530,345,833,482,145,900,000.00$141,922$61,875.67+$547038161900822.06MCYTHW

CYTHW vs PEP: Complete Analysis 2026

CYTHWStock

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.

Full CYTHW Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this CYTHW vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYTHW vs SCHDCYTHW vs JEPICYTHW vs OCYTHW vs KOCYTHW vs MAINCYTHW vs MOCYTHW vs PMCYTHW vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.